Alternative splicing and protein interaction data sets.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Proteoform medicine: characterizing and targeting protein forms in human disease.Nature reviews. Genetics · 2026
   Review
2. Network medicine in Cardiovascular Research.Cardiovascular research · 2021
   Review
3. DIGGER: exploring the functional role of alternative splicing in protein interactions.Nucleic acids research · 2021
   Article
4. Towards a unified open access dataset of molecular interactions.Nature communications · 2020
   Review
5. Network Medicine in Pathobiology.The American journal of pathology · 2019
   Review
6. Extreme multifunctional proteins identified from a human protein interaction network.Nature communications · 2015
   Article
7. Rethinking gene regulatory networks in light of alternative splicing, intrinsically disordered protein domains, and post-translational modifications.Frontiers in cell and developmental biology · 2015
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as